Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment.
De Luca R, Gianotti L, Pedrazzoli P, Brunetti O, Rizzo A, Sandini M, Paiella S, Pecorelli N, Pugliese L, Pietrabissa A, Zerbi A, Salvia R, Boggi U, Casirati A, Falconi M, Caccialanza R. De Luca R, et al. Among authors: brunetti o. Eur J Surg Oncol. 2023 Mar;49(3):542-549. doi: 10.1016/j.ejso.2022.12.006. Epub 2022 Dec 22. Eur J Surg Oncol. 2023. PMID: 36577556 Review.
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Silvestris N, et al. Among authors: brunetti o. Crit Rev Oncol Hematol. 2016 Feb;98:309-24. doi: 10.1016/j.critrevonc.2015.11.016. Epub 2015 Nov 23. Crit Rev Oncol Hematol. 2016. PMID: 26653573 Review.
Multimodal treatment of resectable pancreatic ductal adenocarcinoma.
Silvestris N, Brunetti O, Vasile E, Cellini F, Cataldo I, Pusceddu V, Cattaneo M, Partelli S, Scartozzi M, Aprile G, Casadei Gardini A, Morganti AG, Valentini V, Scarpa A, Falconi M, Calabrese A, Lorusso V, Reni M, Cascinu S. Silvestris N, et al. Among authors: brunetti o. Crit Rev Oncol Hematol. 2017 Mar;111:152-165. doi: 10.1016/j.critrevonc.2017.01.015. Epub 2017 Feb 4. Crit Rev Oncol Hematol. 2017. PMID: 28259290 Free article. Review.
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).
Pedrazzoli P, Silvestris N, Santoro A, Secondino S, Brunetti O, Longo V, Mancini E, Mariucci S, Rampino T, Delfanti S, Brugnatelli S, Cinieri S. Pedrazzoli P, et al. Among authors: brunetti o. ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017. ESMO Open. 2017. PMID: 29209521 Free PMC article.
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper.
Silvestris N, Argentiero A, Cosmai L, Porta C, Gesualdo L, Brunori G, Brunetti O, Rampino T, Secondino S, Rizzo G, Pedrazzoli P. Silvestris N, et al. Among authors: brunetti o. Crit Rev Oncol Hematol. 2019 Aug;140:39-51. doi: 10.1016/j.critrevonc.2019.05.016. Epub 2019 May 31. Crit Rev Oncol Hematol. 2019. PMID: 31176271 Free article. Review.
Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.
Pezzilli R, Caccialanza R, Capurso G, Brunetti O, Milella M, Falconi M. Pezzilli R, et al. Among authors: brunetti o. Cancers (Basel). 2020 Jan 22;12(2):275. doi: 10.3390/cancers12020275. Cancers (Basel). 2020. PMID: 31979186 Free PMC article. Review.
Evolving pancreatic cancer treatment: From diagnosis to healthcare management.
Milella M, Bassi C, Boggi U, Brunetti O, Cavaliere A, Crippa S, De Vita F, Falconi M, Frassineti GL, Giommoni E, Macchini M, Malleo G, Silvestris N, Tudisco A, Vasile E, Reni M. Milella M, et al. Among authors: brunetti o. Crit Rev Oncol Hematol. 2022 Jan;169:103571. doi: 10.1016/j.critrevonc.2021.103571. Epub 2021 Dec 16. Crit Rev Oncol Hematol. 2022. PMID: 34923121 Review.
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M, Silvestris N, Malleo G, Mafficini A, Maggino L, Cocomazzi A, Veghini L, Mombello A, Pezzini F, Sereni E, Martelli FM, Gkountakos A, Ciaparrone C, Piredda ML, Ingravallo G, Paolino G, Nappo F, Rapposelli IG, Frassinetti L, Saragoni L, Lonardi S, Pea A, Paiella S, Fassan M, Brunetti O, Cingarlini S, Salvia R, Milella M, Corbo V, Lawlor RT, Scarpa A, Luchini C. Simbolo M, et al. Among authors: brunetti o. Mod Pathol. 2023 Sep;36(9):100251. doi: 10.1016/j.modpat.2023.100251. Epub 2023 Jun 22. Mod Pathol. 2023. PMID: 37355152 Free article.
Mapping the landscape of immunonutrition and cancer research: a comprehensive bibliometric analysis on behalf of NutriOnc Research Group.
De Felice F, Cattaneo CG, Poto GE, Antropoli C, Brillantino A, Carbone L, Brunetti O, De Luca R, Desideri I, Incorvaia L, La Mendola R, Marmorino F, Parini D, Rodriquenz MG, Salvestrini V, Sebastiani F, Polom K, Marano L. De Felice F, et al. Among authors: brunetti o. Int J Surg. 2024 Jan 1;110(1):395-405. doi: 10.1097/JS9.0000000000000783. Int J Surg. 2024. PMID: 37737933 Free PMC article.
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.
Berardi R, Torniai M, Pusceddu S, Spada F, Ibrahim T, Brizzi MP, Antonuzzo L, Ferolla P, Panzuto F, Silvestris N, Partelli S, Ferretti B, Freddari F, Gucciardino C, Testa E, Concas L, Murgioni S, Bongiovanni A, Zichi C, Riva N, Rinzivillo M, Brunetti O, Giustini L, Di Costanzo F, Delle Fave G, Fazio N, De Braud F, Falconi M, Cascinu S. Berardi R, et al. Among authors: brunetti o. Cancer Med. 2017 Jul;6(7):1493-1499. doi: 10.1002/cam4.1028. Epub 2017 May 25. Cancer Med. 2017. PMID: 28547856 Free PMC article.
162 results